
Hemazide O 200mg Tablet
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Azacitidine (200mg)
Overview Hemazide O 200mg Tablet
Azidex 200mg tablets are indicated in the management of specific hematologic malignancies. They're employed in the treatment of adults diagnosed with all Myelodysplastic Syndrome (MDS) subtypes. Additional applications may be determined by a physician. Azidex 200mg tablets can be administered with or without food, but consistent daily timing is recommended. Dosage and frequency are physician-determined, varying based on the treated condition and potentially adjusted over time. Adhere strictly to prescribed instructions; improper use or overdose may lead to severe adverse reactions. Therapeutic effects might not be evident for weeks or months; discontinue only under medical guidance. Common side effects encompass emesis, asthenia, nausea, and pyrexia. Report concerning symptoms immediately. Mitigation strategies may be available. Vaccination during treatment requires prior physician consultation. Regular hematologic monitoring, including cardiac, hepatic, and renal function assessments, is crucial. Pre-treatment disclosure of pre-existing hepatic or renal impairment, or concurrent use of anti-infectives, is essential. Potential drug interactions exist; inform your doctor of all medications currently used. This medication is contraindicated during pregnancy and lactation.
Uses of Hemazide O 200mg Tablet
Myelodysplastic syndromes: Blood cancer therapies
Major Benefits of Hemazide O 200mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Hemazide O 200mg Tablets can be consumed with or without food, however, consistent timing is recommended for optimal results.
Common Side effects of Hemazide O 200mg Tablet:
- Vomiting
- Weakness
- Nausea
- Decreased potassium level in blood
- Bruise
- Fever
- Chills
- Diarrhea
- Constipation
How to use Hemazide O 200mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Hemazide O 200mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Hemazide O 200mg Tablet works:
Leukemia patients may be prescribed Hemazide O 200mg tablets, an antineoplastic agent. Its mechanism of action involves disrupting the cancerous cells' DNA and RNA replication, thereby inducing cell death. Consequently, this facilitates the healthy development and maturation of new blood cells within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Hemazide O 200mg Tablets may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Hemazide O 200mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
The medication Hemazide O 200mg tablets should not be taken while breastfeeding due to the potential for infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by Hemazide O 200mg Tablet side effects, including fatigue. The 200mg Hemazide O Tablet may induce drowsiness, potentially impacting driving safety.
KidneyCAUTION
Patients with kidney impairment should use Hemazide O 200mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverCAUTION
Patients with liver disease should use Hemazide O 200mg Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Hemazide O 200mg Tablets are contraindicated for individuals with advanced hepatocellular carcinoma.
What if you forget to take Hemazide O 200mg Tablet :
NA
Facts to Know About Hemazide O 200mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine Nucleoside Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Metabolic antagonists |
